MedPath

Effects of Knee Injections on Patients With Knee Osteoarthritis

Phase 4
Conditions
Injection
Effect of Drug
Knee Osteoarthritis
Interventions
Drug: vitagen plus hyruan
Drug: normal saline plus hyruan
Registration Number
NCT05220527
Lead Sponsor
Taipei Medical University
Brief Summary

Using a double-blind, randomized, placebo-controlled design to compare the immediate, short-term, and intermediate-term additional therapeutic effects of ultrasound-guided corticosteroid injection and dextrose injection to hyaluronic acid injection on patients with knee osteoarthritis, under the basis of International Classification of Functioning, Disability and Health.

Detailed Description

A total of 60 patients will be collected. The participants will be randomized into three groups, including the hyaluronic acid combined corticosteroid group, hyaluronic acid combined dextrose group, and hyaluronic acid combined normal saline group (placebo group). The functional performance and knee-related quality of life (Western Ontario and McMaster Universities Osteoarthritis index、Knee Injury and Osteoarthritis Outcome Score), pain (pressure threshold by pain pressure ergometer), and physical activity (10 meters normal and fast walk, up and downstairs, 5 repeated chair-rising time, timed up and go test) and image progression by high-resolution ultrasound will be evaluated before treatment, one week after injections, one month after injections, three months after injections, and six months after injections.

Participants and evaluators will be both blinded to the group's allocation during the whole course of intervention.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
60
Inclusion Criteria
  1. clinical diagnosis of knee osteoarthritis
  2. can walk for 15 meters
  3. Kellgren-Lawrence grade 2 or greater
  4. can follow up for 6 months
Exclusion Criteria
  1. Major diseases will affect balance, such as stroke
  2. infectious disease,
  3. rheumatoid arthritis,
  4. malignancy
  5. pregnancy or prepare to pregnant
  6. received knee injections in the past 6 months
  7. previous knee operation history

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Experimentalvitagen plus hyruanvitagen plus hyruan injection
Study groupTriamcinolone plus hyruantriamcinolone plus hyruan injection
Placebonormal saline plus hyruannormal saline plus hyruan injection
Primary Outcome Measures
NameTimeMethod
Western Ontario and McMaster Universities Osteoarthritis indexchanges of scores from baseline to at one week, one month, 3 months, and 6 months after 3 times of injections

assess knee related performance, scores: 0-100, higher score indicates a worse outcome

Secondary Outcome Measures
NameTimeMethod
physical functional performance-walkingchanges of time (seconds) from baseline to at one week, one month, 3 months, and 6 months after 3 times of injections

10 meters normal and fast walking speed

physical functional performance-balancechanges of time (seconds) from baseline to at one week, one month, 3 months, and 6 months after 3 times of injections

time for up and go test

physical functional performance-stairs climbingchanges of time (seconds) from baseline to at one week, one month, 3 months, and 6 months after 3 times of injections

time for up and down stairs

physical functional performance-chair risingchanges of time (seconds) from baseline to at one week, one month, 3 months, and 6 months after 3 times of injections

time for 5 repeated chair-rising time

Knee Injury and Osteoarthritis Outcome Scorechanges of scores from baseline to at one week, one month, 3 months, and 6 months after 3 times of injections

assess knee osteoarthritis related function, scores: 0-100, higher score indicates a better outcome

Trial Locations

Locations (1)

Shin Kong Wu Ho-Su Memorial Hospital

🇨🇳

Taipei, Taiwan

© Copyright 2025. All Rights Reserved by MedPath